These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 6525200)

  • 1. In vivo actions of bestatin-related compounds in relation to their actions in vitro.
    Aoyagi T; Wada T; Ohuchi S; Kawamura K; Fukatsu S; Umezawa H
    Biochem Int; 1984 Nov; 9(5):643-50. PubMed ID: 6525200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different enzymatic oscillations in vivo caused by the stereoisomers of an aminopeptidase inhibitor, bestatin.
    Aoyagi T; Wada T; Yamamoto K; Kojima F; Nagai M; Harada S; Umezawa H
    J Appl Biochem; 1984 Aug; 6(4):212-21. PubMed ID: 6520072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low molecular weight immunomodifiers produced by microorganisms.
    Umezawa H; Ishizuka M
    Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23 Suppl 1():S9-13. PubMed ID: 3842696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oscillation of enzyme networks in spleen triggered by an immunopotentiator, bestatin.
    Aoyagi T; Wada T; Ohuchi S; Kojima F; Nagai M; Kawahara F; Umezawa H
    Biochem Int; 1984 Oct; 9(4):405-11. PubMed ID: 6097256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aminopeptidase inhibitor ubenimex (bestatin) inhibits the growth of human choriocarcinoma in nude mice through its direct cytostatic activity.
    Inoi K; Goto S; Nomura S; Isobe K; Nawa A; Okamoto T; Tomoda Y
    Anticancer Res; 1995; 15(5B):2081-7. PubMed ID: 8572606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress in the development of bestatin analogues as aminopeptidases inhibitors.
    Chen L; Teng Y; Xu W
    Curr Med Chem; 2011; 18(7):964-76. PubMed ID: 21254977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enkephalin degradation in the guinea-pig ileum: effect of aminopeptidase inhibitors, puromycin and bestatin.
    Cohen ML; Geary LE; Wiley KS
    J Pharmacol Exp Ther; 1983 Feb; 224(2):379-85. PubMed ID: 6822962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recovery from cyclophosphamide-induced myelosuppression accelerated by bestatin].
    Uchida K; Kohi F; Yorimitsu S; Takahashi I; Kitajima K; Kimura I
    Gan To Kagaku Ryoho; 1982 Feb; 9(2):220-4. PubMed ID: 7184398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of arginine aminopeptidase by bestatin and arphamenine analogues. Evidence for a new mode of binding to aminopeptidases.
    Harbeson SL; Rich DH
    Biochemistry; 1988 Sep; 27(19):7301-10. PubMed ID: 3207677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of fiber cell globulization and hyperglycemia-induced lens opacification by aminopeptidase inhibitor bestatin.
    Chandra D; Ramana KV; Wang L; Christensen BN; Bhatnagar A; Srivastava SK
    Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2285-92. PubMed ID: 12091429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological role and degradation processes of neuromedin N in the gastrointestinal tract: an in vitro and in vivo study.
    Barelli H; Woskowska Z; Cipris S; Fox-Threlkeld JE; Daniel EE; Vincent JP; Checler F
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1300-7. PubMed ID: 8531096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Similar effects of various low-molecular-weight enzyme inhibitors on enzyme networks in dystrophic mice.
    Aoyagi T; Wada T; Ohuchi S; Kojima F; Nagai M; Harada S; Umezawa H
    J Pharmacobiodyn; 1984 Sep; 7(9):681-7. PubMed ID: 6527211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent studies on antibiotics and small molecular immunomodulators with potential usefulness in treating lung cancer: Part II - Small molecular weight immunomodulators produced by microorganisms.
    Umezawa H
    Int J Clin Pharmacol Ther Toxicol; 1982 Jan; 20(1):19-23. PubMed ID: 7056602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of splenic enzyme activities by administration of aminopeptidase N (CD13) inhibitors: relationship between actions in vivo and in vitro.
    Kocha T; Ohtsuka E; Funahashi T; Fukuda T; Aoyagi T; Wanda T; Takeuchi T
    J Enzyme Inhib; 1994; 8(3):187-95. PubMed ID: 7539487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous modulation of transport and metabolism of acyclovir prodrugs across rabbit cornea: An approach involving enzyme inhibitors.
    Katragadda S; Talluri RS; Mitra AK
    Int J Pharm; 2006 Aug; 320(1-2):104-13. PubMed ID: 16720085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of bestatin and muramyl-dipeptide on macrophage-bound aminopeptidase.
    Wachsmuth ED; Wüst B
    Hoppe Seylers Z Physiol Chem; 1981 May; 362(5):563-8. PubMed ID: 7250904
    [No Abstract]   [Full Text] [Related]  

  • 18. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel mammalian high-molecular-weight aminopeptidase.
    Erbeznik H; Hersh LB
    Arch Biochem Biophys; 1997 Aug; 344(1):228-34. PubMed ID: 9244402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Low-molecular weight immunostimulants: cell membrane enzyme inhibitors].
    Lin ZB; Shi JP
    Sheng Li Ke Xue Jin Zhan; 1985 Apr; 16(2):115-20. PubMed ID: 3892667
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.